These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Other 2022-003788-13 Molecular theranostics for metastatic prostate cancer: PSMA, FAPI, or both? Metastaattisen eturauhassyövän teranostiikka: PSMA, FAPI vai molemmat? not-yet-due